BACKGROUND: Liver diseases are the leading causes of death in human immunodeficiency virus (HIV)-positive persons since the widespread use of combination antiretroviral treatment (cART). Most of these deaths are due to hepatitis C (HCV) or B (HBV) virus coinfections. Little is known about other causes. Prolonged exposure to some antiretroviral drugs might increase hepatic mortality. METHODS: All patients in the Data Collection on Adverse Events of Anti-HIV Drugs study without HCV or HBV coinfection were prospectively followed from date of entry until death or last follow-up. In patients with liver-related death, clinical charts were reviewed using a structured questionnaire. RESULTS: We followed 22 910 participants without hepatitis virus coinfection for 114 478 person-years. There were 12 liver-related deaths (incidence, 0.10/1000 person-years); 7 due to severe alcohol use and 5 due to established ART-related toxicity. The rate of ART-related deaths in treatment-experienced persons was 0.04/1000 person-years (95% confidence interval, .01, .10). CONCLUSIONS: We found a low incidence of liver-related deaths in HIV-infected persons without HCV or HBV coinfection. Liver-related mortality because of ART-related toxicity was rare.
BACKGROUND:Liver diseases are the leading causes of death in human immunodeficiency virus (HIV)-positive persons since the widespread use of combination antiretroviral treatment (cART). Most of these deaths are due to hepatitis C (HCV) or B (HBV) virus coinfections. Little is known about other causes. Prolonged exposure to some antiretroviral drugs might increase hepatic mortality. METHODS: All patients in the Data Collection on Adverse Events of Anti-HIV Drugs study without HCV or HBV coinfection were prospectively followed from date of entry until death or last follow-up. In patients with liver-related death, clinical charts were reviewed using a structured questionnaire. RESULTS: We followed 22 910 participants without hepatitis virus coinfection for 114 478 person-years. There were 12 liver-related deaths (incidence, 0.10/1000 person-years); 7 due to severe alcohol use and 5 due to established ART-related toxicity. The rate of ART-related deaths in treatment-experienced persons was 0.04/1000 person-years (95% confidence interval, .01, .10). CONCLUSIONS: We found a low incidence of liver-related deaths in HIV-infectedpersons without HCV or HBV coinfection. Liver-related mortality because of ART-related toxicity was rare.
Authors: Olivia Keiser; Jacques Fellay; Milos Opravil; Hans H Hirsch; Bernard Hirschel; Enos Bernasconi; Pietro L Vernazza; Martin Rickenbach; Amalio Telenti; Hansjakob Furrer Journal: Antivir Ther Date: 2007
Authors: E Rosenthal; D Salmon-Céron; C Lewden; V Bouteloup; G Pialoux; F Bonnet; M Karmochkine; T May; M François; C Burty; E Jougla; D Costagliola; P Morlat; G Chêne; P Cacoub Journal: HIV Med Date: 2009-02-15 Impact factor: 3.180
Authors: Anna Conen; Jan Fehr; Tracy R Glass; Hansjakob Furrer; Rainer Weber; Pietro Vernazza; Bernard Hirschel; Matthias Cavassini; Enos Bernasconi; Heiner C Bucher; Manuel Battegay Journal: Antivir Ther Date: 2009
Authors: Sophia Saifee; Dean Joelson; James Braude; Roshan Shrestha; Mark Johnson; Marty Sellers; Michael R Galambos; Raymond A Rubin Journal: Clin Gastroenterol Hepatol Date: 2008-07-17 Impact factor: 11.382
Authors: Helen Kovari; Bruno Ledergerber; Ulrich Peter; Markus Flepp; Josef Jost; Patrick Schmid; Alexandra Calmy; Nicolas J Mueller; Beat Muellhaupt; Rainer Weber Journal: Clin Infect Dis Date: 2009-08-15 Impact factor: 9.079
Authors: Andrew M Gross; Philipp A Jaeger; Jason F Kreisberg; Katherine Licon; Kristen L Jepsen; Mahdieh Khosroheidari; Brenda M Morsey; Susan Swindells; Hui Shen; Cherie T Ng; Ken Flagg; Daniel Chen; Kang Zhang; Howard S Fox; Trey Ideker Journal: Mol Cell Date: 2016-04-21 Impact factor: 17.970
Authors: Caryn G Morse; Mary McLaughlin; Lindsay Matthews; Michael Proschan; Francine Thomas; Ahmed M Gharib; Mones Abu-Asab; Abigail Orenstein; Ronald E Engle; Xiaojun Hu; Richard Lempicki; Colleen Hadigan; David E Kleiner; Theo Heller; Joseph A Kovacs Journal: Clin Infect Dis Date: 2015-02-13 Impact factor: 9.079
Authors: Michael S Saag; Andrew O Westfall; Stephen R Cole; William C Mathews; Daniel R Drozd; Kenneth H Mayer; Greer A Burkholder; Mari Kitahata; Eric M Maiese Journal: J Acquir Immune Defic Syndr Date: 2017-01-01 Impact factor: 3.731